198 related articles for article (PubMed ID: 21752644)
21. Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring N
Chen D; Zheng W
Bioorg Med Chem Lett; 2016 Nov; 26(21):5234-5239. PubMed ID: 27707605
[TBL] [Abstract][Full Text] [Related]
22. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
Hirsch BM; Zheng W
Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
[TBL] [Abstract][Full Text] [Related]
23. A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation.
Galleano I; Schiedel M; Jung M; Madsen AS; Olsen CA
J Med Chem; 2016 Feb; 59(3):1021-31. PubMed ID: 26788965
[TBL] [Abstract][Full Text] [Related]
24. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation.
Fatkins DG; Monnot AD; Zheng W
Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
Kiviranta PH; Salo HS; Leppänen J; Rinne VM; Kyrylenko S; Kuusisto E; Suuronen T; Salminen A; Poso A; Lahtela-Kakkonen M; Wallén EA
Bioorg Med Chem; 2008 Sep; 16(17):8054-62. PubMed ID: 18701307
[TBL] [Abstract][Full Text] [Related]
26. Sirtuins inhibitors: the approach to affinity and selectivity.
Cen Y
Biochim Biophys Acta; 2010 Aug; 1804(8):1635-44. PubMed ID: 19931429
[TBL] [Abstract][Full Text] [Related]
27. Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing.
Uciechowska U; Schemies J; Neugebauer RC; Huda EM; Schmitt ML; Meier R; Verdin E; Jung M; Sippl W
ChemMedChem; 2008 Dec; 3(12):1965-76. PubMed ID: 18985648
[TBL] [Abstract][Full Text] [Related]
28. Some thiocarbamoyl based novel anticathepsin agents.
Kaur R; Raghav N
Bioorg Chem; 2020 Nov; 104():104174. PubMed ID: 32932119
[TBL] [Abstract][Full Text] [Related]
29. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
[TBL] [Abstract][Full Text] [Related]
31. Cyclic Tripeptide-based Potent and Selective Human SIRT5 Inhibitors.
Jiang Y; Zheng W
Med Chem; 2020; 16(3):358-367. PubMed ID: 31161996
[TBL] [Abstract][Full Text] [Related]
32. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
Huhtiniemi T; Suuronen T; Lahtela-Kakkonen M; Bruijn T; Jääskeläinen S; Poso A; Salminen A; Leppänen J; Jarho E
Bioorg Med Chem; 2010 Aug; 18(15):5616-25. PubMed ID: 20630764
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of novel sirtuin inhibitor scaffolds.
Sanders BD; Jackson B; Brent M; Taylor AM; Dang W; Berger SL; Schreiber SL; Howitz K; Marmorstein R
Bioorg Med Chem; 2009 Oct; 17(19):7031-41. PubMed ID: 19734050
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
[TBL] [Abstract][Full Text] [Related]
35. A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice.
Greco MN; Connelly MA; Leo GC; Olson MW; Powell E; Huang Z; Hawkins M; Smith C; Schalk-Hihi C; Darrow AL; Xin H; Lang W; Damiano BP; Hlasta DJ
Bioorg Med Chem Lett; 2013 May; 23(9):2595-7. PubMed ID: 23528297
[TBL] [Abstract][Full Text] [Related]
36. Cyclic peptide-based potent human SIRT6 inhibitors.
Liu J; Zheng W
Org Biomol Chem; 2016 Jul; 14(25):5928-35. PubMed ID: 27248480
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and inhibitory activity of substrate-analog fructosyl peptide oxidase inhibitors.
Watanabe B; Ichiyanagi A; Hirokawa K; Gomi K; Nakatsu T; Kato H; Kajiyama N
Bioorg Med Chem Lett; 2015 Sep; 25(18):3910-3. PubMed ID: 26235953
[TBL] [Abstract][Full Text] [Related]
38. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificity of SIRT1-catalyzed lysine Nepsilon-deacetylation reaction probed with the side chain modified Nepsilon-acetyl-lysine analogs.
Jamonnak N; Hirsch BM; Pang Y; Zheng W
Bioorg Chem; 2010 Feb; 38(1):17-25. PubMed ID: 19914676
[TBL] [Abstract][Full Text] [Related]
40. Structure-based development of novel sirtuin inhibitors.
Schlicker C; Boanca G; Lakshminarasimhan M; Steegborn C
Aging (Albany NY); 2011 Sep; 3(9):852-72. PubMed ID: 21937767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
